Alzheimer's & Dementia
Changes in serum β-synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome
Cross-sectional study of 131 peopleDown syndrome
Papers by Olivia Belbin
16 results
- Lancet
Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study
Cohort study of 4,804 peopleDown syndrome - Research Square
Pre-dementia clinical trajectories associated with neuronal α-synuclein neuropathologic change: a retrospective cohort study
Preprint: cohort study of 1,543 peopleDementia - Research Square
Does CSF testing add value after an indeterminate plasma p-tau217 result?
Preprint: study in peopleBiomarkers
- American Journal of Human Genetics
Exome analysis of 22,319 individuals links extremely rare copy-number variants and 22q11.21 dosage to Alzheimer risk
Study in peopleMechanisms - AAIC 2025 Abstract
Unveiling the Temporal Dynamics of White Matter Hyperintensities Related to Alzheimer's Disease in Down Syndrome
Study in peoplePopulations - AAIC 2025 Abstract
Early Detection of White Matter Integrity Changes in Down Syndrome: The Promise of PSMD as a Sensitive Biomarker
Study in peopleBiomarkers - AAIC 2025 Abstract
Unveiling the Temporal Dynamics of White Matter Hyperintensities Related to Alzheimer’s Disease in Down Syndrome
Study in peoplePopulations - AAIC 2025 Abstract
Early Detection of White Matter Integrity Changes in Down Syndrome: The Promise of PSMD as a Sensitive Biomarker
Study in peopleBiomarkers